Feed OZEM
OZ

Roundhill Investments - GLP-1 & Weight Loss ETF OZEM NASDAQ · Financials · United States

$29.72 -2.20% -$0.67

Summary

Roundhill Investments - GLP-1 & Weight Loss ETF is an ETF - a fund traded on an exchange like a stock - run by Roundhill Investments. Positions inside: 24. The ten largest make up 72% of the fund.

Yearly costs
0.59%
Fund size
$57.5M
Positions
24
Dividend yield
1.38%
Running since
2024

What speaks for it

Nothing stands out in its favour.

What to watch

  • The ten largest positions make up 72% of the fund, so its result rests on a few names.
  • 100% of the fund is in one sector (Healthcare).
  • Costs of 0.59% a year are above the middle of comparable funds (0.45%).
  • A young fund: it has been running only since 2024.
  • A small fund with $57.5M under management; small funds get closed more often.
  • It trades little: only about $442.2K changes hands a day.

A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.

Price

Performance

1 month
+2.2%
3 months
-13%
This year
-13%
1 year
-8.6%
Avg. market cap
$345.1B
P/E
19.8x
Forward P/E
17.1x
P/S
4.9x
P/B
3.2x
P/FCF
24.1x
EV/EBITDA
12.8x
Dividend yield
1.50%
ROIC
9.1%
ROE
20.7%
Gross margin
40.6%
Operating margin
-2,722.7%
Net margin
-2,422.5%
Payout ratio
29.7%
Net debt/EBITDA
0.5x
Beta
0.47

Weighted average of the 21 largest companies, which make up 99% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.

What is inside?

Concentrated
  1. 1
    LL
    Eli Lilly LLY 20%
  2. 2
    NV
    Novo Nordisk NVO 11%
  3. 3
    12
    Hanmi Pharm. Co., Ltd. 128940.KS 7.0%
  4. 4
    45
    Chugai Pharmaceutical Co., Ltd. 4519.T 6.8%
  5. 5
    PF
    Pfizer PFE 5.7%
  6. 6
    KL
    Kailera Therapeutics, Inc. KLRA 4.9%
  7. 7
    10
    CSPC Pharmaceutical Group Limited 1093.HK 4.6%
  8. 8
    12
    Jiangsu Hengrui Pharmaceuticals Co.,Ltd 1276.HK 4.2%
  9. 9
    VK
    Viking Therapeutics VKTX 3.9%
  10. 10
    36
    Hansoh Pharmaceutical Group Company Limited 3692.HK 3.8%

Positions in the fund: 24. The ten largest make up 72% of it.

Composition as of Nov 14, 2026.

Where is it spread?

One sector dominates

By sector

By country

By company size

By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.

Largest sector: Healthcare (100%). Largest country: United States (46%). Largest size group: Large cap (38%).

What does it cost me?

Expensive
A year from $10,000
$59.00
Over 20 years
$2,828

From every $10,000 invested the fund takes $59.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,828.

How has it done?

Losing value
Over the last year
-8.6%
Deepest drop
-29%
Yearly volatility
23%

Decline over the last year: 8.6%. Deepest drop in these years: 29% below the earlier high.

Does it pay dividends?

Yes, it pays out
Yield
1.38%
Last payment
$0.41

Over the last 12 months it paid $0.41 per share, which is 1.38% of today's price. The last payment was $0.41 on Dec 30, 2025.

Is it easy to buy and sell?

It trades little
Traded a day
$442.2K
Shares a day
15K

On an average day about $442.2K of the fund changes hands.

How expensive are the companies inside?

Usual valuation
P/E of the companies inside
19.8
Average Bulios Score
67 out of 100

Weight by Bulios Fair Price

On average the companies inside trade for 19.8 times their yearly profit. By Fair Price, 44% of the rated weight comes out as undervalued.

Counted from its largest companies (21), which make up 99% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.

Similar funds

Funds that hold much of the same. The overlap says how much of their weight they share with this fund.

Fund Domicile Size 1-year change Dividends
TH
THNR Amplify ETF Trust
United States 0.59% $5.22M -0.4% Pays out 63%
PP
PPH VanEck Pharmaceutical ETF
United States 0.36% $1.10B +19% Pays out 34%
PE
PEPT REX Peptide ETF
United States 0.65% $3.39M - - 30%
ME
MEDX Horizon Kinetics Medical ETF
United States 0.85% $17.9M +12% Pays out 30%
IH
IHE iShares U.S. Pharmaceuticals ETF
United States 0.37% $1.26B +30% Pays out 25%
FP
FPHAX Fidelity Select Pharmaceuticals· mutual fund
- - $1.38B +19% Pays out 24%

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy